Thyroid cancer in children: A multicenter international study highlighting clinical features and surgical outcomes of primary and secondary tumors.

cancer carcinoma children surgery thyroid

Journal

Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492

Informations de publication

Date de publication:
2022
Historique:
received: 07 04 2022
accepted: 24 06 2022
entrez: 8 8 2022
pubmed: 9 8 2022
medline: 9 8 2022
Statut: epublish

Résumé

Thyroid gland malignancies are rare in pediatric patients (0.7% of tumors); only 1.8% are observed in patients aged <20 years, with a higher prevalence recorded in women and adolescents. Risk factors include genetic syndromes, MEN disorders, autoimmune diseases, and exposure to ionizing radiation. Radiotherapy is also associated with an increased risk of secondary thyroid cancer. This study describes the clinical features and surgical outcomes of primary and secondary thyroid tumors in pediatric patients. Institutional data were collected from eight international surgical oncology centers for pediatric patients with thyroid cancer between 2000 and 2020. Statistical analyses were performed using the GraphPad Prism software. Among 255 total cases of thyroid cancer, only 13 (5.1%) were secondary tumors. Primary thyroid malignancies were more likely to be multifocal in origin (odds ratio [OR] 1.993, 95% confidence interval [CI].7466-5.132, This multicenter study demonstrated excellent survival in pediatric thyroid malignancies. Secondary tumors exhibited greater disease relapse (15.8 vs. 10.5%) and a higher incidence of surgical complications (36.8 vs. 22.2%).

Sections du résumé

Background UNASSIGNED
Thyroid gland malignancies are rare in pediatric patients (0.7% of tumors); only 1.8% are observed in patients aged <20 years, with a higher prevalence recorded in women and adolescents. Risk factors include genetic syndromes, MEN disorders, autoimmune diseases, and exposure to ionizing radiation. Radiotherapy is also associated with an increased risk of secondary thyroid cancer. This study describes the clinical features and surgical outcomes of primary and secondary thyroid tumors in pediatric patients.
Methods UNASSIGNED
Institutional data were collected from eight international surgical oncology centers for pediatric patients with thyroid cancer between 2000 and 2020. Statistical analyses were performed using the GraphPad Prism software.
Results UNASSIGNED
Among 255 total cases of thyroid cancer, only 13 (5.1%) were secondary tumors. Primary thyroid malignancies were more likely to be multifocal in origin (odds ratio [OR] 1.993, 95% confidence interval [CI].7466-5.132,
Conclusions UNASSIGNED
This multicenter study demonstrated excellent survival in pediatric thyroid malignancies. Secondary tumors exhibited greater disease relapse (15.8 vs. 10.5%) and a higher incidence of surgical complications (36.8 vs. 22.2%).

Identifiants

pubmed: 35935364
doi: 10.3389/fped.2022.914942
pmc: PMC9354958
doi:

Types de publication

Journal Article

Langues

eng

Pagination

914942

Informations de copyright

Copyright © 2022 Martucci, Crocoli, De Pasquale, Spinelli, Strambi, Brazzarola, Morelli, Cassiani, Mancera, Luengas, Lobos, Liberto, Astori, Sarnacki, Couloigner, Simon, Lambert, Abib, Cervantes, Caran, Delgado Lindman, Jones, Shukla, Losty and Inserra.

Références

Radiat Res. 2018 Aug;190(2):117-132
pubmed: 29763379
Semin Pediatr Surg. 2012 Feb;21(1):44-50
pubmed: 22248969
Arch Otolaryngol Head Neck Surg. 2009 Jan;135(1):88-94
pubmed: 19153313
J Cancer Surviv. 2017 Jun;11(3):302-308
pubmed: 28028762
Adv Pediatr. 2017 Aug;64(1):171-190
pubmed: 28688588
J Clin Endocrinol Metab. 2000 Sep;85(9):3227-32
pubmed: 10999813
Cancer. 2003 May 15;97(10):2397-403
pubmed: 12733137
Thyroid. 2017 Mar;27(3):412-417
pubmed: 27855574
Thyroid. 2009 May;19(5):479-85
pubmed: 19226197
Endocr Relat Cancer. 2016 Jun;23(6):R299-321
pubmed: 27229933
Eur J Epidemiol. 2018 Dec;33(12):1139-1162
pubmed: 30511135
J Pediatr Surg. 2011 May;46(5):823-8
pubmed: 21616234
Eur J Surg Oncol. 2019 Nov;45(11):2001-2002
pubmed: 31474417
Am J Otolaryngol. 2019 May - Jun;40(3):431-434
pubmed: 30956005
Otolaryngol Head Neck Surg. 2017 May;156(5):794-802
pubmed: 28322121
Endocr Rev. 2011 Dec;32(6):798-826
pubmed: 21880704
Ann Surg Oncol. 2008 Apr;15(4):1169-76
pubmed: 18246401
Eur J Cancer. 2002 Mar;38(5):645-7
pubmed: 11916545
Thyroid. 2015 Jul;25(7):716-59
pubmed: 25900731
Am J Surg. 2012 Dec;204(6):881-6; discussion 886-7
pubmed: 23026382
Surgery. 1994 Dec;116(6):1036-40; discussion 1040-1
pubmed: 7985084
Radiat Res. 2006 Oct;166(4):618-28
pubmed: 17007558
Curr Pediatr Rev. 2016;12(4):247-252
pubmed: 27745544
Thyroid. 2013 Jul;23(7):805-10
pubmed: 23286372
J Surg Res. 2009 Sep;156(1):167-72
pubmed: 19631341
PLoS One. 2013;8(4):e59709
pubmed: 23573208
J Clin Endocrinol Metab. 2009 Jun;94(6):2085-91
pubmed: 19293268
J Natl Compr Canc Netw. 2010 Nov;8(11):1289-300
pubmed: 21081785
J Surg Res. 2012 Oct;177(2):268-74
pubmed: 22795270
J Clin Endocrinol Metab. 2014 Jun;99(6):E1072-7
pubmed: 24617712

Auteurs

Cristina Martucci (C)

Department of Pediatric Surgery, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Alessandro Crocoli (A)

Department of Pediatric Surgery, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Maria Debora De Pasquale (MD)

Department of Pediatric Hematology/Oncology Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Claudio Spinelli (C)

Department of Pediatric Surgery, University of Pisa, Pisa, Italy.

Silvia Strambi (S)

Department of Pediatric Surgery, University of Pisa, Pisa, Italy.

Paolo Brazzarola (P)

Department of Surgery and Oncology, University and Hospital Trust of Verona, Verona, Italy.

Eleonora Morelli (E)

Department of Surgery and Oncology, University and Hospital Trust of Verona, Verona, Italy.

Jessica Cassiani (J)

Department of Hepatobiliary Surgery, University of Verona, Verona, Italy.

Juliana Mancera (J)

Department of Pediatric Surgery, Universidad Militar Nueva Granada, Bogotá, Colombia.

Juan Pablo Luengas (JP)

Department of Pediatric Oncology, National Cancer Institute, Liverpool, Colombia.

Pablo Lobos (P)

Department of Pediatric Surgery, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Daniel Liberto (D)

Department of Pediatric Surgery, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Estefanìa Astori (E)

Department of Pediatric Surgery, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Sabine Sarnacki (S)

Department of Pediatric Surgery, Necker-Enfants Malades Hospital, Université de Paris, Paris, France.

Vincent Couloigner (V)

Department of Pediatric Otolaryngology, Necker-Enfants Malades Hospital, Université de Paris, Paris, France.

François Simon (F)

Department of Pediatric Otolaryngology, Necker-Enfants Malades Hospital, Université de Paris, Paris, France.

Cassandre Lambert (C)

Department of Pediatric Otolaryngology, Necker-Enfants Malades Hospital, Université de Paris, Paris, France.

Simone de Campos Vieira Abib (SCV)

Department of Pediatric Oncology Surgery and Pediatric Oncology, Pediatric Oncology Institute-GRACC, Federal University of São Paulo, São Paulo, Brazil.

Onivaldo Cervantes (O)

Department of Head and Neck Surgery, Federal University of São Paulo, São Paulo, Brazil.

Eliana Caran (E)

Department of Pediatric Oncology Surgery and Pediatric Oncology, Pediatric Oncology Institute-GRACC, Federal University of São Paulo, São Paulo, Brazil.

Diana Delgado Lindman (D)

Department of Pediatric Oncology Surgery and Pediatric Oncology, Pediatric Oncology Institute-GRACC, Federal University of São Paulo, São Paulo, Brazil.

Matthew O Jones (MO)

Department of Pediatric Surgery, Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, United Kingdom.

Rajeev Shukla (R)

Department of Pathology, Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, United Kingdom.

Paul D Losty (PD)

Department of Pediatric Surgery, Faculty of Health and Life Sciences, Alder Hey Children's Hospital NHS Foundation Trust, University of Liverpool, Liverpool, United Kingdom.

Alessandro Inserra (A)

Department of Pediatric Surgery, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Classifications MeSH